Abstract
This study aimed to develop a simple method for synthesis of vitamin c-coated selenium nanoparticles which were then labeled with technetium-99m for further in vivo studies on normal and solid tumor induced mice. Results showed the formation of amorphous SeNPs with a mean size of (23 ± 5 nm). The radiolabelling yield of [99mTc-Vit_C (SeNPs)] was (96 ± 2%) with stability up to 6 h. Effective target non-target ratios were obtained in solid tumor-induced mice throughout the experimental time points. [99mTc-Vit_C (SeNPs)] complex showed promising features which make it a potential radiopharmaceutical for imaging of solid tumors.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Sakr TM, Korany M, Katti KV (2018) Selenium nanomaterials in biomedicine—an overview of new opportunities in nanomedicine of selenium. J Drug Deliv Sci Technol 46:223–233
El-Sayed MA (2001) Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res 34(4):257–264
McConnell WP et al (2000) Electronic and optical properties of chemically modified metal nanoparticles and molecularly bridged nanoparticle arrays. J Phys Chem B 104(38):8925–8930
Swidan MM et al (2019) Iron oxide nanoparticulate system as a cornerstone in the effective delivery of Tc-99 m radionuclide: a potential molecular imaging probe for tumor diagnosis. Daru 27(1):49–58
Sakr TM et al (2018) I-131 doping of silver nanoparticles platform for tumor theranosis guided drug delivery. Eur J Pharm Sci 122:239–245
Psimadas D et al (2013) Radiolabeling approaches of nanoparticles with 99mTc. Contrast Media Mol Imaging 8(4):333–339
Thurman JM, Serkova NJ (2013) Nanosized contrast agents to noninvasively detect kidney inflammation by magnetic resonance imaging. Adv Chronic Kidney Dis 20(6):488–499
Sonkusre P, Cameotra SS (2017) Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation. J Nanobiotechnology 15(1):43
Abdulah R et al (2005) Chemical forms of selenium for cancer prevention. J Trace Elem Med Biol 19(2):141–150
Zhai X et al (2017) Antioxidant capacities of the selenium nanoparticles stabilized by chitosan. J Nanobiotechnol 15(1):4
Bai K et al (2017) Selenium nanoparticles-loaded chitosan/citrate complex and its protection against oxidative stress in d-galactose-induced aging mice. J Nanobiotechnol 15(1):92
Wang HG et al (2007) Modelling of batch fluidised bed drying of pharmaceutical granules. Chem Eng Sci 62(5):1524–1535
Pi J et al (2013) Pathway of cytotoxicity induced by folic acid modified selenium nanoparticles in MCF-7 cells. Appl Microbiol Biotechnol 97(3):1051–1062
Xia Y et al (2015) Novel functionalized selenium nanoparticles for enhanced anti-hepatocarcinoma activity in vitro. Nanoscale Res Lett 10(1):1051
Nie T et al (2016) Facile synthesis of highly uniform selenium nanoparticles using glucose as the reductant and surface decorator to induce cancer cell apoptosis. J Mater Chem B 4(13):2351–2358
Tan L et al (2009) In vitro study on the individual and synergistic cytotoxicity of adriamycin and selenium nanoparticles against Bel7402 cells with a quartz crystal microbalance. Biosens Bioelectron 24(7):2268–2272
Li Y et al (2018) Multifunctional selenium nanoparticles with Galangin-induced HepG2 cell apoptosis through p38 and AKT signalling pathway. R Soc Open Sci 5(11):180509
Li Y et al (2016) Multifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cells. Int J Nanomed 11:3065–3076
Xia Y et al (2019) Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma. Drug Deliv 26(1):1–11
Malhotra S et al (2016) In vitro and in vivo antioxidant, cytotoxic, and anti-chronic inflammatory arthritic effect of selenium nanoparticles. J Biomed Mater Res B Appl Biomater 104(5):993–1003
Yazdi MH et al (2012) The immunostimulatory effect of biogenic selenium nanoparticles on the 4T1 breast cancer model: an in vivo study. Biol Trace Elem Res 149(1):22–28
Menon S et al (2018) Selenium nanoparticles: A potent chemotherapeutic agent and an elucidation of its mechanism. Colloids Surf B Biointerfaces 170:280–292
Bijur GN et al (1997) Antimutagenic and promutagenic activity of ascorbic acid during oxidative stress. Environ Mol Mutagen 30(3):339–345
Padh H (1991) Vitamin C: newer insights into its biochemical functions. Nutr Rev 49(3):65–70
Fairfield KM, Fletcher RH (2002) Vitamins for chronic disease prevention in adults: scientific review. JAMA 287(23):3116–3126
Levine M (1986) New concepts in the biology and biochemistry of ascorbic acid. N Engl J Med 314(14):892–902
Levine M et al (1356S) Determination of optimal vitamin C requirements in humans. The American journal of clinical nutrition 62(6 Suppl):1347S–1356S
Jacob RA, Sotoudeh G (2002) Vitamin C function and status in chronic disease. Nutr Clin Care 5(2):66–74
Yigit US et al (2006) Preparation of (99m)Tc labeled vitamin C (ascorbic acid) and biodistribution in rats. Chem Pharm Bull 54(1):1–3
Zhang C et al (2015) Synthesis, characterization, and controlled release of selenium nanoparticles stabilized by chitosan of different molecular weights. Carbohyd Polym 134:158–166
Motaleb MA et al (2016) An easy and effective method for synthesis and radiolabelling of risedronate as a model for bone imaging. J Label Compd Radiopharm 59(4):157–163
Vilchis-Juárez A et al (2014) Molecular targeting radiotherapy with cyclo-RGDFK(C) peptides conjugated to 177Lu-labeled gold nanoparticles in tumor-bearing mice. J Biomed Nanotechnol 10(3):393–404
Lettré R et al (1972) Sublines of the Ehrlich-Lettré mouse ascites tumour: a new tool for experimental cell research. Die Naturwissenschaften 59(2):59–63
Ibrahim A et al (2014) Formulation and preclinical evaluation of 99mTc–gemcitabine as a novel radiopharmaceutical for solid tumor imaging. J Radioanal Nucl Chem 302:179–186
Yigit US et al (2006) Preparation of (99m)Tc labeled vitamin C (ascorbic acid) and biodistribution in rats. Chem Pharm Bull (Tokyo) 54(1):1–3
Baba K et al (1999) Tc-glutathione complex (Tc-GSH): labelling, chemical characterization and biodistribution in rats. Met Based Drugs 6(6):329–336
Wongso H, Zainuddin N, Iswahyudi I (2014) Biodistribution and imaging of the 99mTc-glutathione radiopharmaceutical in white rats induced with cancer. Atom Indones 39:106
Decuzzi P et al (2017) Nano-particles for biomedical applications. Springer, Berlin, pp 643–691
Yang J, Yang K-Q, Qiu L (2017) Biosynthesis of vitamin C stabilized tin oxide nanoparticles and their effect on body weight loss in neonatal rats. Environ Toxicol Pharmacol 54:48–52
Malassis L et al (2016) One-step green synthesis of gold and silver nanoparticles with ascorbic acid and their versatile surface post-functionalization. RSC Advances 6(39):33092–33100
Piacenza E et al (2018) Physical-chemical properties of biogenic selenium nanostructures produced by Stenotrophomonas maltophilia SeITE02 and Ochrobactrum sp. MPV1. Front Microbiol 9:3178
Almeida JP et al (2011) In vivo biodistribution of nanoparticles. Nanomedicine (Lond) 6(5):815–835
Nune SK et al (2009) Nanoparticles for biomedical imaging. Expert Opin Drug Deliv 6(11):1175–1194
Thyagarajan A, Sahu RP (2018) Potential contributions of antioxidants to cancer therapy: immunomodulation and radiosensitization. Integr Cancer Ther 17(2):210–216
Sznarkowska A et al (2017) Inhibition of cancer antioxidant defense by natural compounds. Oncotarget 8(9):15996–16016
Wu X, Cheng J, Wang X (2017) Dietary Antioxidants: Potential Anticancer Agents. Nutr Cancer 69(4):521–533
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Korany, M., Mahmoud, B., Ayoub, S.M. et al. Synthesis and radiolabeling of vitamin C-stabilized selenium nanoparticles as a promising approach in diagnosis of solid tumors. J Radioanal Nucl Chem 325, 237–244 (2020). https://doi.org/10.1007/s10967-020-07195-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-020-07195-5